Introduction: Nephrotic syndrome induced by adriamycin (ADR) is an experimental model of glomerulosclerosis in humans. The AT 1 receptor for angiotensin II (Ang II) is involved in the renal expression of the nuclear factor-kappa B (NF-ΚB) during this nephrosis. NF-ΚB is a transcription factor for proinflammatory effects of Ang II; however, there is no information about the role of this receptor in the renal proinflammatory events in ADR nephrosis.
Introduction
Angiotensin II (Ang II) is a molecule considered a growth factor that regulates events such as apoptosis, cell proli feration and renal fibrosis. 13 In recent years it has been demonstrated that Ang II regulates the renal recruitment of inflammatory cells and the activation of NFkB. 4, 5 Ang II also induces the expression of adhesion molecules VCAM1, ICAM1 and Pselectins, promoting the recruitment of leuko cytes and modulating local inflammatory response. 6 Ang II exerts all of its biological properties through two subclasses of receptors: AT 1 and AT 2 . 7,8 AT 1 mainly participates in blood pressure control, water-electrolyte balance, and also regu lates proinflammatory genes. 9 AT 2 is involved in cell growth inhibition, diuresis/natriuresis, glomerular monocyte infiltra tion, and renal nitric oxide (NO) production. 1012 AT 1 receptor antagonists and angiotensinconverting enzyme inhibitors have been used to reduce renal injury. 13 In experimental models of chronic renal diseases, such as renal mass ablation and in accelerated passive Heymann nephritis, antagonists of AT 1 receptor have shown renoprotective effects. 1316 Adriamycin (ADR)induced nephrotic syndrome (NS) in the rat is an experimental nephropathy which is charac terised by glomerular and tubular dysfunction. This nonhypertensive experimental model, that mimics focal and segmental glomerulosclerosis and other renal diseases such as diabetic nephropathy in humans, is characterised by massive proteinuria, hypoalbuminaemia, dyslipidae mia, hypercoagulability, oedema and ascites formation. 17, 18 Renal fibrogenic properties of Ang II were found to be diminished when angiotensin IIconverting enzyme inhibi tors and AT 1 receptor antagonists, respectively, were used in this experimental model. 19, 20 In addition, improved glomerular filtration and reduced progression to glomeru losclerosis have been found after AT 1 receptor antagonist treatment in spontaneously hypertensive rats with ADR nephrosis. 21 These data suggest a role for Ang II in glo merulosclerosis during ADR nephrosis. However, there is no information relating to the classical inflammatory path ways involving Ang II and its AT 1 receptor during experi mental ADR nephrosis. Since proteinuria (an important finding in nephrosis) is associated with oxidant stress and inflammation, and Ang II has proinflammatory effects in the kidney, 1, 4, 5 this study aimed to investigate the role of Ang II in the renal expression of intercellular adhesion molecule1 (ICAM1), macrophage infiltration, the pro duction of superoxide anion (O 2 ), and the role of AT 1 receptors in those events in ADR nephrosis induced in rats.
Materials and methods

Experimental design
Male SpragueDawley rats weighing 200-250 g were injected intravenously (tail vein) with a single dose of 6 mg/kg bw of adriablastine 22 (ADR, doxorubicin chlorhydrate, Pfizer Venezuela, SA) diluted in 0.9% saline solution (nephrotic syndrome: NS, n = 20). Control rats were injected only with saline solution (Cont, n = 10). Three days before ADR admin istration, a group of NS rats (n = 10) received daily 15 mg/kg bw of losartan 23 (Cozaar, sodium losartan, Merck & CO, USA) orally via gavage (NS + Los). Weekly, nephrotic and control rats were individually housed in metabolic cages for 24 h to collect urine samples, in order to determine protein urinary concentration by the sulfosalicylic acid method and creatinine content; at this time rat body weight was also deter mined. Animals were sacrificed 4 weeks after ADR adminis tration, and blood samples were taken by abdominal aortic puncture under ether anaesthesia to determine serum choles terol and triglyceride concentrations by enzymatic methods (Cholesterol: CHODPAP. Triglycerides: GPOPAP; Roche/ Hitachi 902, USA) and creatinine by a direct colorimetric method (Laboratories Biogamma C.A., Caracas, Venezuela). The glomerular filtration rate (GFR) was estimated using the serum and urinary creatinine values. Thereafter, kidneys were perfused with saline solution and rapidly removed, embedded in Tissue Tek (Miles Inc., Diagnostic Division, Kankakee, USA), frozen in acetone and dry ice and stored at 70°C. For histopathological studies, renal biopsies were formalin fixed and paraffin embedded. Experimental procedures followed the ethical guidelines of the committee of bioethical and biosecurity of FONACIT (Caracas, Venezuela) and the com mittee of bioethical of Medical School (Universidad del Zulia, Maracaibo, Venezuela).
Renal histopathological studies
The left kidney was removed under anaesthesia with ether, and processed for light microscopy. Tissue samples were fixed in 10% formalin and embedded in paraffin. Sections (4 μm thick) were stained with the periodic acidSchiff reaction and haematoxylin. The sections were examined using a light microscope (Axioscop, Zeiss, Germany) and pathological alterations were quantified. Quantitative anal ysis of glomerular and mesangial areas was performed using an IA32 system software (LECO Corporation, MI, USA), and the percentage of mesangial area in the glomer ulus was determined. Numbers of tubules with tubular casts, disrupted tubules and glomeruli with focal and seg mental glomerulosclerosis were determined and expressed as percentages. Analysis was performed in at least 100 structures (tubules or glomeruli).
Immunofluorescence studies
Macrophage, Ang II and ICAM1 expression was deter mined in acetonefixed, 4μm frozen renal sections by indirect immunofluorescence, using a monoclonal anti body antirat ED1 for monocyte/macrophages (5 μg/ml, Chemicon International, Inc, USA), a polyclonal rabbit antiangiotensin II (Bachem, USA), and a monoclonal antirat ICAM1 antibody (5 μg/ml, Pierce Biotechnology, Inc, USA), respectively. A secondary antibody, FITC conjugated antimouse IgG (Fab' 2 ) (5 μg/ml, PIERCE Biotechnology, Inc., USA), was used to localise mouse monoclonal antibodies in renal tissues. Rabbit IgG was localised using a secondary antibody, TRICconjugated donkey antirabbit IgG (5 μg/ml, Chemicon International, Inc, USA). The infiltrating cells were expressed as number of cells per glomerular crosssection (GCS) in at least 20 glomeruli and in 20 randomly selected fields of tubulointer stitial areas, and were expressed as number of cells per mm 2 . Glomerular ICAM1 expression was determined with a semiquantitative score according to extent and intensity of fluorescence as follows: 0: negative; 1: weak; 2: mild; and 3: intense. Double staining was performed to determine colocalisation of ED1 molecule and Ang II expression.
Renal superoxide anion production
Superoxide anion production was determined as previously described. 24 Briefly, unfixed renal frozen sections (10 μm) were incubated for 1 h at 37°C in a solution containing 0.05 M TrisHCl buffer, 10% NaN 3 , 8% NiCl, 0.5 M MnCl 2 , and 0.05 M DAB, pH 7.6. Afterwards, renal sections were fixed with 10% formalin, and counterstained with 1% methyl green. Finally, the positive cells were determined in glomerular (cells per GCS), tubular and interstitial areas (cells per mm 2 of tubulointerstitium).
Statistical analysis
Data were expressed as mean ± standard deviation (SD). Statistical comparison between groups was performed using oneway analysis of variance (ANOVA) followed by the Bonferroni posttest. Correlations were determined by Pearson's correlation test. Statistical significance was assumed when twotailed p < 0.05.
Results
Values for body weight, serum cholesterol and serum trig lycerides 4 weeks after ADR administration are given in Table 1 . Body weight gain was lower in nephrotic animals (NS and NS + Los groups) than in control rats. This param eter was also lower in the NS + Los group when compared with the NS group. Increased serum levels of cholesterol and triglycerides were observed in nephrotic animals. Proteinuria was present in all ADR rats 1 week after the administration of ADR (Figure 1) , and it was associated with increased levels of cholesterol and triglycerides, indicating a nephrotic state. Losartan treatment (15 mg/kg bw) failed to reduce levels of cholesterol and triglycerides in NS rats (Table 1) ; nevertheless, proteinuria was reduced at the third and fourth weeks in losartantreated animals (Figure 1) . GFR values in losartantreated and untreated nephrotic rats were not sig nificantly different (0.15 ± 0.1 and 0.14 ± 0.1 ml/min, respectively), but were significant lower when compared with healthy controls (0.35 ± 0.15 ml/min: p < 0.05).
Kidneys from nephrotic rats showed severe and exten sive damage at week 4 after ADR administration. There was an increased percentage of tubular casts with tubular dilation, leading to disruption of tubular basement mem brane. Focal and segmental glomerulosclerosis were also found in nephrotic rats. Increased mesangial matrix expan sion (percentage of mesangial area) was observed in kid neys from nephrotic rats when compared with control rats. Losartan treatment did not prevent the morphological changes observed in ADR nephrosis ( Table 2) .
ADR caused increased monocyte/macrophage infiltra tion in glomeruli and in the interstitium when compared with control rats. Losartan treatment decreased macrophage infiltration (Figures 2(A) and (B) ). The expression of adhesion molecules (ICAM1) that may be involved in mac rophage infiltration was also investigated. Overexpression of ICAM1 in glomeruli, interstitium and in tubules was induced by ADR. Losartan treatment reduced the expres sion of this adhesion molecule in all evaluated renal compartments (Figures 2(C)(E)). Superoxide anion production was evaluated to investigate oxidative stress in nephrotic rats. Increased interstitial superoxide anion pro duction was observed; however, in glomeruli and tubules this failed to reach statistical significance. Losartan treat ment diminished superoxide anion production in glomeruli and tubules (Figures 2(F)(H) ).
Ang II expression was significantly higher in all renal compartments in nephrotic rats (Figures 2(I)(K)). and Figure 3 ). In general, the content of Ang II in nephrotic ani mals treated with losartan was decreased (mainly in tubules and interstitial cells) when compared with untreated nephrotic animals; however, this failed to reach statistical significance. Intense glomerular, tubular and interstitial positive zones for this molecule (accumules) were observed in nephrotic animals (glomerular accumules: Control: 0; ADR: 0.1440 ± 0.1753; ADR + losartan: 0.2160 ± 0.2404 per glomerular crosssection. Interstitial accumules: Control: 0; ADR: 5.488 ± 3.87; ADR + losartan: 6.064 ± 4.424 per mm 2 of tubulointerstitial area. Tubular lumen accumules: Control: 0; ADR: 4.88 ± 3.31; ADR + losartan: 4.576 ± 3.9968 per mm 2 of tubulointerstitial area). Losartan did not significantly modify the expression of these Ang II deposits. Double staining for ED1 and Ang II showed no colocalisation of either molecule (Figure 4 ).
Ang II expression was correlated with glomerular (p = 0.0256) and interstitial (p < 0.0001) ED1 positive cells, and with glomerular (p = 0.0002), interstitial (p < 0.0001) and tubular expression of ICAM1 (p = 0.0022). Tubular expression of Ang II correlated with tubular superoxide positive cells (p = 0.0256) ( Table 3 ). Macrophage renal infiltration was correlated with glomerular and interstitial ICAM1 expression (p < 0.0001) and with interstitial super oxide anion production (p = 0.0240) ( Table 4 ).
Discussion
During recent years there has been a large rise in the number of studies trying to clarify the role of Ang II in activating proinflammatory pathways responsible for the production of mediators implicated in the pathogenesis of renal diseases. 25, 26 Through interactions with AT 1 and AT 2 recep tors, Ang II is able to activate NFkB, inducing the expres sion of proinflammatory events. 4 The diverse effects of Ang II on the kidney include mesangial cell growth and cytokine and chemokine release from renal cells leading to macro phage infiltration. 5, 2729 In ADRinduced nephrosis, ED1 positive cell infiltration is a hallmark that precedes the development of tubular cell atrophy. 30 In this study, increased expression of renal Ang II, ICAM1, macrophage infiltration and O 2 production was observed during ADRinduced neph rosis. Losartan reduced the number of infiltrating ED1 positive cells and the expression of ICAM1, suggesting a role of Ang II through the AT 1 receptor. Accordingly, it has been demonstrated that Ang II upregulates ICAM1 expres sion in HUVECs via AT 1 receptors. 31 Since ICAM1 is impli cated in the tissue infiltration of monocyte/macrophages, the reduced ICAM1 expression induced by losartan could explain the reduced ED1 cell infiltration observed in this study. However, since reduced ED1 expression did not reach normal levels, we cannot rule out other Ang IIdependent mechanisms that may be involved in the renal monocyte/ macrophage infiltration during ADRinduced nephrosis. In this regard, translocation of NFkB and MCP1 production in this experimental model could have a role. 3235 Renal cells are able to synthesise renin and prorenin/ renin receptors, 36 angiotensinogen and Ang II receptors, 37 making the kidney an organ capable of producing and main taining high levels of intrarenal Ang II. Once Ang II is produced in the kidney it could promote proinflammatory cytokine production, inducing immune cell infiltration and the progression of renal injury. In this study, renal Ang II was overexpressed in nephrotic rats. Losartan treatment decreased Ang II content (mainly in tubules and interstitial cells) but failed to reach statistical significance. In this regard, increased intrarenal Ang II activates AT 1 receptors in the proximal tubular cell followed by expression of angi otensinogen, renin, and angiotensinconverting enzyme. As a result, angiotensinogen and Ang I are catalyzed in situ, and can be released to the extracellular space. Losartan can directly abrogate activation of AT 1 receptors. In addition, the proximal tubule is innervated by renal sympathetic nerve termini, whose subsequent catecholamine release in turn stimulates α2/β1 receptors. AT 1 receptors are located at the nerve terminals. Losartan is also able to attenuate activa tion of the intrarenal reninangiotensin system by inhibiting renal sympathetic outflow. 3842 These data could explain the tendency to decreased intrarenal Ang II found in losartan treated nephrotic animals. As an interesting point, losartan significantly decreased inflammatory parameters, while intrarenal Ang II content was still increased (compared with normal values). In this regard, losartan is an antagonist of the AT 1 receptor and also decreases the expression of AT 1 receptors in glomerulonephritis, 43 leading to reduced Ang II effects in the tissue; in our case, diminished renal expression of Ang II proinflammatory effects (ICAM1, monocyte/macrophage infiltration, 0 2 ). Regarding this, similar findings have been reported in other models of neph ropathy. 44 Therefore, AT 1 receptor blockade could be more important than the intrarenal content of Ang II. As an inter esting finding, acellular accumulation of Ang II reactive zones was observed in glomeruli, interstitium and tubular lumen. We do not have a clear explanation for this phenom enon; however, it could represent local disruption of Ang IIpositive cells, local extracellular production of Ang II, or intratubular secretion of this molecule by tubular cells.
During this study monocyte/macrophages failed to express intracellular Ang II, suggesting a marginal role for these cells as a source of this peptide in this experimental model. Since previous reports 45 have shown that macro phages are capable of producing angiotensinconverting enzyme, a role for extracellular Ang II formation can not be ruled out. In addition, intrinsic renal cells are capable of producing this molecule; 46,47 therefore, a role for mesangial cell, tubular cells and interstitial cells can be expected. In this regard, increased Ang II reactivity was observed in all renal compartments.
Reactive oxygen species (ROS) produced during ADR induced nephrosis play an important role in the pathogenesis of this experimental model. 48 Elevated Ang II expression promotes the activation of NADPHoxidase via the AT 1 receptor, and this represents an important source of ROS, which eventually lead to increase of O 2 generation and other ROS. 49, 50 In this study, and consistent with those reports, animals with ADRinduced nephrosis showed over production of O 2 ; this effect was diminished by losartan, suggesting an antioxidant effect of this antagonist, probably due to the inhibition of an Ang II NAD(P)H oxidase inducer effect with further decreased production of O 2 . 51 Our data showed severe renal structural damage and massive proteinuria in all nephrotic animals. Losartan had a moderate antiproteinuric effect after 3 weeks of treatment; however, this antagonist did not prevent the histopathologi cal alterations observed in this model. These data suggest a nonAng IIdependent toxic effect of ADR on renal tissue, in addition to Ang II proinflammatory effects. Thus, pro teinuria inducer mechanisms in this model of nephrosis are probably in part related to the toxic effect of ADR, reflected in tubular damage and in part related to the inflammatory actions of Ang II through AT 1 receptors. The extent of glomerulosclerosis and mesangial expansion were not modified by losartan treatment. In this regard, previous reports have shown that AT 1 antagonism did not diminish the fibrogenic effect of Ang II in ADR nephrosis; 19 how ever, this point is controversial. 20 In addition to proteinuria, renal functional disturbance was observed in nephrotic ani mals, as shown by the reduced GFR in those animals. This effect was not AT 1 receptor dependent, since losartan treated and untreated nephrotic animals had similar degree of GFR reduction. Although we have no clear explanation for this reduced renal function, mechanisms related to decreased glomerular colloid osmotic pressure, increased osmotic pressure in Bowman's capsule induced by pro teinuria and structural damage could be involved.
Conclusions
In conclusion, during the course of ADRinduced nephrosis in rats, renal Ang II may have an important proinflamma tory effect, increasing ICAM1 expression, monocyte/mac rophage infiltration, oxidative stress and proteinuria, probably mediated by AT 1 receptors. Further experiments are required to determine the effect of combined treatment (blocking of Ang II receptors and synthesis) and the role of AT 2 receptors in this experimental model.
